Abstract In synovial-like membranes from failed total hip prostheses, an increased level of cytokines and cellular mediators has been identified. We compared two matched groups of patients with total hip arthroplasty (THA)-one with surgically proven component loosening and one without. We measured serum levels of interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and elastase. Soluble interleukin 2 receptor (sIL-2r) was also measured to exclude any hypersensitivity reaction. We found no significant difference in serum values between groups. Neither were there any differences with respect to implant material, mode of fixation, and periprosthetic osteolysis. In contrast to previous reports, our results suggest that serum levels of cytokines and cellular mediators may not be affected in aseptic loosening.
Introduction
There are only a few publications evaluating bone resorbing cytokines in patients with aseptic loosening. These reports have suggested that some cellular products-interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF)-may be useful as early markers of implant failure [5, 9] . The aim of this study was to evaluate whether aseptic loosening generates a systemic response and whether increased serum levels of IL-6, GM-CSF, and elastase occur as a consequence.
Materials and methods
We evaluated 23 patients with aseptic loosening of total hip arthroplasty (THA) undergoing revision surgery. Definite loosening was confirmed in all patients at surgery. The degree of radiographic osteolysis was graded according to the criteria of Paprosky et al. [16] . Twenty-three patients without clinical or radiological signs of loosening were matched for age, gender, and time of follow-up, and served as control group. Only individuals without allergies, rheumatoid arthritis, autoimmune diseases, and immunosuppressive therapy were included. A drug history was taken and any prolonged therapy with nonsteroidal antiinflammatory drugs (NSAID) was noted.
The group with loosening comprised 13 men and ten women with a median age of 65 (45-77) years. The mean time of implantation was 8.6 (0.5-13) years (Table 1 ). In the control group there were 11 men and 12 women with a median age of 67 (34-81) years at a mean of 84 (06-16) years after primary THA. There were 17 uncemented, five cemented, and one hybrid THA in the loosening group; and 16 uncemented, five cemented, and two hybrid THA in the control group. All patients had polyethylene (PE) components/inlays on the acetabular side articulating with ceramic femoral heads.
Blood samples were collected as fasting morning specimens in commercially available tubes by peripheral venipuncture within 24 h prior to surgery and centrifuged at 1,800 rpm for 15 min. The samples were aliquotted and stored at −20°C until processing. Before assay analysis the samples were thawed to room temperature and swirled gently to mix the sample. Only non-haemolysed and non-lipaemic samples were processed.
The serum level of IL-6 was measured using an automated chemi-luminescent immunometric assay Immulite Analyzer (Immulite IL-6, DPC Biermann, Bad Nauheim, Germany). Serum levels of IL-2 receptor and GM-CSF were measured using commercially available ELISA assays (IL-2 receptor: Interleukin-2-receptor Milenia, DPC Biermann, Bad Nauheim, Germany; GM-CSF: EH-GMCSF, Endogen, Boston, USA). Endogenous elastase/α1-proteinase-inhibitor levels in plasma were measured and used to determine elastase activity (elastase: PMN-Elastase Milenia, DPC Biermann, Bad Nauheim. Germany). All concentrations below the detection limits of the assays, defined as the concentration two standard deviations above the response at zero dose limit, were recorded as non-detectable (IL-6: 5 pg/ml; GM-CSF: 2 pg/ml; elastase: 3 ng/ml; sIL-2r: 16 U/ml). Data were statistically analysed by descriptive and interference statistical methods. Significance was determined by using the Wilcoxon's signed rank test, with a p value of less than 0.05 considered as statistically significant. The study was approved by the appropriate ethics committee and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All persons gave their informed consent prior inclusion.
Results
Soluble IL-2r levels Serum levels for sIL-2r as an indicator of hypersensitivity reaction of the implant ranged from 165.11 to 808.99 (mean 469.20) U/ml in the loosening group and from 222.03 to 897.35 (mean 515.00) U/ml in the control group, with no significant difference.
Interleukin 6 levels IL-6 levels ranged from non-detectable in both groups to 14.9 pg/ml in patients with aseptic loosening and 19.1 pg/ml in the control group. The mean serum levels did not differ significantly (study group: 3.97 pg/ml, control group: 4.08 pg/ml).
Granulocyte-macrophage colony-stimulating factor
Detectable serum GM-CSF levels were measured in one patient with aseptic loosening with a value of 4.8 pg/ml. In all other patients no elevated serum levels could be noted (Table 2 ).
Elastase
Elastase levels were not elevated either in the loosening group (58.91; range: 22.6-241.9 ng/ml) or in the control group (56.56; range: 16.7-217 ng/ml).
Diagnosis, age, gender, implant material (Table 3) , NSAID therapy, extent of radiographic osteolysis, dura- tion of time in situ, and mode of fixation showed no correlation with the markers measured.
Discussion
The complex mechanism of aseptic loosening in THA is not yet fully understood [11, 14] . In recent years attention has been more and more focused on the biological response to wear debris [14] . Wear particles stimulate macrophages to release cytokines and proteolytic enzymes, as shown in a number of in vivo and in vitro studies [10, 13] . Cytokines and other mediators that stimulate bone resorption, such as IL-1, IL-6, tumour necrosis factor (TNF)-α, GM-CSF, and elastase, have been identified to contribute to the process of loosening [1, 18, 20] . We limited our study to three of these bioactive substances (IL-6, GM-CSF, and elastase), all known to be involved in the regulation of bone remodelling. Since the measured cytokines can also be involved during a specific immune response, we assayed the serum levels of sIL-2r known as an indicator for a specific immune response [7] . IL-2, which is produced by activated T cells in an autocrine fashion, stimulates growth and proliferation of antigen-specific T-lymphocytes [2] . The synthesis and secretion of IL-2 and the expression of high-affinity IL-2 receptor represent early consequences of antigen-induced activation of a small soluble fraction of this protein. In agreement with the findings of other authors [5, 8] sIL-2r levels were not affected in our study. thus eliminating a hypersensitivity reaction to implants.
One of the major cytokines involved in inflammatory response and periprosthetic loosening is IL-6, which is secreted by several cell types including macrophages [4, 17] . IL-6 has been reported to stimulate bone resorption via osteoclast activation [15] . Several authors have shown in in vitro experiments that titanium alloy and polymethylmethacrylate particles can induce the release of IL-6 from macrophages [3] . There is evidence that CrCoMb may not trigger IL-6 production to the same extent [6] . Clinical studies evaluating serum levels of cytokines [5, 9] in patients with loosened implants support these in vitro results. However, we failed to detect a similar difference in our study with no detectable IL-6 levels in more than half of the patients in the loosening group. In contrast to previously published studies [5, 9] , we were unable to demonstrate a statistically significant relationship between the increase of IL-6 and other variables such as osteolysis, mode of fixation, and time of follow-up. This is in accordance with Kim [12] who was unable to demonstrate any IL-6 in 25 patients with failed THA.
Elastase, a proteolytic enzyme produced by polymorphonuclear neutrophil granulocytes (PMN) and other cells [19] , has been suggested to be another important factor in periprosthetic loosening. Takagi et al. [18] demonstrated immunohistochemically elevated levels of elastase and its endogenous inhibitor α1-antitrypsin in periprosthetic tissues retrieved from revised loosened hip implants. To our knowledge no studies have been published with regard to serum levels of elastase. We could not detect elevated plasma levels of this proteolytic enzyme in either group.
Significantly elevated serum levels of GM-CSF in patients with loosened hip prostheses were described by Granchi et al. [9] . This biochemical parameter is a pleiotropic cytokine that can stimulate the proliferation, maturation, and function of haematopoietic cells. It is released by osteoblasts in response to TNF and is known to induce proliferation and maturation of progenitor cells, which have the capacity to differentiate into macrophages. Granchi et al. also described the highest cytokine levels in patients treated with NSAID. None of their findings could be confirmed in our study. Granchi et al. reported about an eight-fold higher level of GM-CSF in patients with loosened prosthesis. However, they used healthy individuals with no implants in situ as a control.
Although our patient material has similar radiographic gradings of osteolysis, we were unable to confirm the observation that GM-CSF levels decreased with increasing extent of osteolysis [5] . We can only speculate that when osteolysis is radiographically evident-as in all our patients with loosening-a cytokine response is not detectable. This would support Granchi´s hypothesis that GM-CSF levels represent a very early response, before radiographic manifestation becomes evident.
This study does not support previous reports. The contrasting findings therefore reduce the potential value of these serum markers to detect early aseptic prosthetic loosening.
